Araceli Biosciences
Araceli Biosciences develops advanced technologies combining high-content imaging hardware and AI-based software to accelerate drug discovery. Their product portfolio includes the Araceli Endeavor® line of scalable imaging systems and software solutions like EndeavorOS, ClaireRT, and Clairvoyance™ for image acquisition and analysis. The company aims to transform drug discovery by reducing screening times from 45 minutes to 4 minutes per plate, enabling faster therapeutic breakthroughs. With leadership experienced in biotech and a focus on predictive AI-driven image acquisition and analysis, Araceli targets pharmaceutical and biotech researchers to improve therapeutic success and patient outcomes.
Araceli Biosciences
Araceli Biosciences develops advanced technologies combining high-content imaging hardware and AI-based software to accelerate drug discovery. Their product portfolio includes the Araceli Endeavor® line of scalable imaging systems and software solutions like EndeavorOS, ClaireRT, and Clairvoyance™ for image acquisition and analysis. The company aims to transform drug discovery by reducing screening times from 45 minutes to 4 minutes per plate, enabling faster therapeutic breakthroughs. With leadership experienced in biotech and a focus on predictive AI-driven image acquisition and analysis, Araceli targets pharmaceutical and biotech researchers to improve therapeutic success and patient outcomes.
